openPR Logo
Press release

Global Kidney Cancer Drugs and Companies Pipeline Review H2 2017

01-03-2018 11:18 AM CET | Health & Medicine

Press release from: WISE GUY RESEARCH CONSULTANTS PVT LTD

/ PR Agency: WISE GUY RESEARCH CONSULTANTS PVT LTD
Global Kidney Cancer

Global Kidney Cancer

Summary
Kidney cancer also called renal cancer is a disease in which kidney cells become malignant (cancerous) and grows out of control, forming a tumor. Symptoms include blood in urine, loss of appetite, fever that lasts for weeks, extreme fatigue, and anemia, shortness of breath and bone pain. Treatment includes surgery, radiation therapy and chemotherapy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2659610-kidney-cancer-renal-cell-cancer-pipeline-review-h2-2017

Companies mentioned
4SC AG
Aadi Bioscience Inc
AbbVie Inc
Actuate Therapeutics Inc
Adaptimmune Therapeutics Plc
Aduro BioTech Inc
Advanced Cancer Therapeutics LLC
Advenchen Laboratories LL
Biotest AG
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Co
Calithera Biosciences Inc
CASI Pharmaceuticals Inc
CBT Pharmaceuticals Inc
Celgene Corp
Celldex Therapeutics Inc
Cellectar Biosciences Inc
Show more…

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Kidney Cancer (Renal Cell Cancer) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Kidney Cancer (Renal Cell Cancer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 1, 15, 94, 88, 5, 78, 12 and 4 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 13, 6 and 13 molecules, respectively.

Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Kidney Cancer (Renal Cell Cancer) (Oncology).
- The pipeline guide reviews pipeline therapeutics for Kidney Cancer (Renal Cell Cancer) (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Kidney Cancer (Renal Cell Cancer) (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Kidney Cancer (Renal Cell Cancer) (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Kidney Cancer (Renal Cell Cancer) (Oncology)

Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Kidney Cancer (Renal Cell Cancer) (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
Table of Contents 2
Introduction 8
Kidney Cancer (Renal Cell Cancer) - Overview 9
Kidney Cancer (Renal Cell Cancer) - Therapeutics Development 10
Kidney Cancer (Renal Cell Cancer) - Therapeutics Assessment 49
Kidney Cancer (Renal Cell Cancer) - Companies Involved in Therapeutics Development 73
Kidney Cancer (Renal Cell Cancer) - Drug Profiles 152
Kidney Cancer (Renal Cell Cancer) - Dormant Projects 1368
Kidney Cancer (Renal Cell Cancer) - Discontinued Products 1383
Kidney Cancer (Renal Cell Cancer) - Product Development Milestones 1387
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2659610-kidney-cancer-renal-cell-cancer-pipeline-review-h2-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Kidney Cancer Drugs and Companies Pipeline Review H2 2017 here

News-ID: 883080 • Views:

More Releases from WISE GUY RESEARCH CONSULTANTS PVT LTD

Global LIMS Industry Analysis 2020 Market Growth, Trends, Opportunities And Forecast To 2026
Global LIMS Industry Analysis 2020 Market Growth, Trends, Opportunities And Fore …
LIMS Market 2020-2026 New Study Reports “LIMS Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global LIMS Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, LIMS Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global LIMS Market Is Extensively Assessed In The
Asthma Drugs Market 2020 Global Industry Sales, Supply, Demand, Consumption, Analysis And Forecasts To 2026
Asthma Drugs Market 2020 Global Industry Sales, Supply, Demand, Consumption, Ana …
Asthma Drugs Market 2020-2026 New Study Reports “Asthma Drugs Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global Asthma Drugs Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, Asthma Drugs Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global Asthma Drugs Market Is Extensively Assessed In The Research
Virtual Reality in Education 2020 Global Market Key Players - Alchemy VR, Avantis Education, EON Reality, Google, Oculus VR, Virtalis - Analysis And Forecast To 2026
Virtual Reality in Education 2020 Global Market Key Players - Alchemy VR, Avanti …
Virtual Reality in Education Market 2020-2026 New Study Reports “Virtual Reality in Education Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global Virtual Reality in Education Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, Virtual Reality in Education Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global
Online Jewelry 2020 Global Market Key Players - Cartier, Tiffany & Co, Pandora, Chaumet, Tanishq, Van cleef & arpels-Analysis And Forecast To 2026
Online Jewelry 2020 Global Market Key Players - Cartier, Tiffany & Co, Pandora, …
Online Jewelry Market 2020-2026 New Study Reports “Online Jewelry Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports. Report Summary:- The Global Online Jewelry Market Report 2020-2026 (Forecast Period) Offers An In-Depth Study Of Market Growth Factors, Future Evaluation, Country-Level Analysis, Online Jewelry Market Distribution, And Competitive Landscape Study Of Significant Industry Players. Every Segment Of The Global Online Jewelry Market Is Extensively Assessed In The Research

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For